CMC Strategies and New Technology Applications for the Development of Peptide Drugs
William Fang
VP, Head of New Modality Oligo/Peptide Business, STA Pharmaceutical
The peptide drug market is continually growing at an increasing speed, boosted by fast growing demand, delivery technology advancement and emerging design technologies. CMC strategies and approaches vary depending on the development stages of the product. WuXi STA provides integrated CMC services including both API and drug product for peptides and complex conjugates from discovery to development and commercial manufacturing, and we will discuss our proven CMC strategies and new technology applications how to accelerate peptide drug development to market.